Episode 10 - Future of Psychedelic Psychiatry from PS '17

MAPS Podcast

Live from Psychedelic Science '17 in Oakland, this panel explores the future of psychiatry in the psychedelic context. In this conversational panel format, the conversation discucces with great candor and honesty all the pros, cons, triumphs and setbacks that have occurred within the last 10 years. Dr. Summergrad and Dr. Insel both share their experiences from the mental health and patient-doctor perspective.

Moderated by George Goldsmith and featuring Paul Summergrad, MD, and Thomas Insel, MD.

George Goldsmith is a co-founder and director of COMPASS – a non-profit medical research organisation dedicated to accelerating access to evidence-led innovation in mental health and wellbeing. George’s early training and experience was a blend of cognitive psychology, clinical psychology and computer science.

Paul Summergrad, M.D., is the Dr. Frances S. Arkin professor and chairman of the Department of Psychiatry and professor of medicine at Tufts University School of Medicine and psychiatrist-in-chief at Tufts Medical Center.

Thomas Roland Insel is an American neuroscientist and psychiatrist who led the National Institute of Mental Health (NIMH) from 2002 until November 2015. Prior to becoming Director of NIMH, he was the founding Director of the Center for Behavioral Neuroscience at Emory University in Atlanta, Georgia.